Miami、FLにおけるクローン病の臨床試験
Miamiとその周辺地域（約30マイル以内）の拠点で、クローン病に関する19件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
被験者募集中第3相
- Sanchez Clinical Research ( Site 5144), Miami
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
被験者募集中第2相
- Research Associates of South Florida /ID# 280929, Miami
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
被験者募集中第4相
- Gastro Health Research - Miami, Miami
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
被験者募集中第2相
- A Plus Research /ID# 265878, Miami
- Sanchez Clinical Research /ID# 265887, Miami
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
被験者募集中第3相
- Sanchez Clinical Research, Inc, Miami
- Biodax Medical Research Trials, Miami
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
被験者募集中第2/3相
- Sanchez Clinical Research, Inc, Miami
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
被験者募集中第3相
- Research Associates of South Florida - Miami - Southwest 8th Street, Miami
- Gastro Health Research - Miami, Miami
Tailored Anti-Inflammatory American Diet for Patients With Crohn's Disease
被験者募集中
- University of Miami, Miami
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
被験者募集中第3相
- Columbus Clinical Services LLc-Site Number: 8400038, Miami
- Regis Clinical Research, LLC-Site Number: 8400041, Miami
- Sylvester Comprehensive Cancer Center - A University of Miami Hospital and Clinics Facility - Miami-Site Number: 8400111, Miami
- 他4件
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
被験者募集中第3相
- Columbus Clinical Services LLc-Site Number: 8400038, Miami
- Bioresearch Partner-Kendale Lakes-Site Number: 8400053, Miami
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
被験者募集中第2相
- Bioresearch Partner-Kendale Lakes, Miami
A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
被験者募集中第2相
- Gastro Health Research - Miami, Miami
A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
被験者募集中第2相
- Gastro Health Research - Miami, Miami
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
被験者募集中第3相
- Sanchez Clinical Research, Inc, Miami
Zymfentra (Infliximab-dyyb) REal World Cohort STudy
被験者募集中観察研究
- University of Miami, Miami
Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
被験者募集中第2相
- Research Associates of South Florida, LLC, Miami
Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA) and Diet in Inflammatory Bowel Disease (IBD) Patients
被験者募集中第4相
- University of Miami, Miami
A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease
被験者募集中第2相
- Investigational Site Number 8400028, Miami
- Investigational Site Number: 8400012, Miami
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
被験者募集中第2相
- Mirador Therapeutics Selected Site, Miami
- Mirador Therapeutics Selected Site, Miami
- Mirador Therapeutics Selected Site, Miami
他の都市におけるクローン病の試験
- New York City, NY35件の研究
- Cleveland, OH19件の研究
- St. Louis, MO19件の研究
- Boston, MA19件の研究
- Orlando, FL17件の研究
- Houston, TX17件の研究
- Atlanta, GA17件の研究
- Tyler, TX16件の研究
- San Diego, CA15件の研究
- San Antonio, TX15件の研究
- Los Angeles, CA15件の研究
- Philadelphia, PA13件の研究
Miamiにおける他の研究
- 乳がん42件の研究
- がん（全種類）36件の研究
- 非小細胞肺癌31件の研究
- 前立腺がん27件の研究
- 肥満症27件の研究
- 急性骨髄性白血病24件の研究
- 転移性癌24件の研究
- 卵巣がん23件の研究
- 過体重23件の研究
- 多発性骨髄腫21件の研究
- 潰瘍性大腸炎21件の研究
- アルツハイマー病20件の研究
ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。